Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Brain Neoplasms 16Breast Neoplasms 12Neoplasms 5Neoplasm Metastasis 4Lung Neoplasms 4Glioma 4Colorectal Neoplasms 4Colonic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Lymphoma 3Hematologic Neoplasms 3Fatigue 3Central Nervous System Neoplasms 3Small Cell Lung Carcinoma 2Radiation Injuries 2Neurotoxicity Syndromes 2Meningioma 2Malnutrition 2Leukemia 2Head and Neck Neoplasms 2Glioblastoma 2Ependymoma 2Depression 2Craniopharyngioma 2Burkitt Lymphoma 2Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Testicular Neoplasms 1Salivary Gland Neoplasms 1Rectal Neoplasms 1

Interventions

Carboplatin 88pembrolizumab 85Paclitaxel 71Cyclophosphamide 63Capecitabine 38Doxorubicin 37Taxes 29130-nm albumin-bound paclitaxel 29Cisplatin 25Albumin-Bound Paclitaxel 22Epirubicin 21Drug Therapy 21Docetaxel 20sacituzumab govitecan 19olaparib 19camrelizumab 18atezolizumab 18Gemcitabine 17eribulin 16durvalumab 16Bevacizumab 16Radiotherapy 15toripalimab 14Specimen Handling 14Biopsy 13Everolimus 12Magnetic Resonance Spectroscopy 11apatinib 10Nivolumab 10talazoparib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Triple Negative Breast Neoplasms × Mental Status and Dementia Tests × Clear all
NCT06582615 2025-12-11

MIND-TNBC

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
60 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡